Rossari Biotech Limited

Informe acción NSEI:ROSSARI

Capitalización de mercado: ₹40.2b

Salud financiera de hoja de balance de Rossari Biotech

Salud financiera controles de criterios 5/6

Rossari Biotech tiene un patrimonio de accionistas total de ₹9.8B y una deuda total de ₹1.3B, lo que sitúa su ratio deuda-patrimonio en 13.5%. Sus activos y pasivos totales son ₹15.3B y ₹5.6B respectivamente. El BAIT de Rossari Biotech es de ₹1.7B, por lo que su ratio de cobertura de intereses es de 9.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹791.1M.

Información clave

10.1%

Ratio deuda-patrimonio

₹1.06b

Deuda

Ratio de cobertura de intereses9.8x
Efectivo₹677.94m
Patrimonio₹10.48b
Total pasivo₹5.24b
Activos totales₹15.72b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹8.4B) de ROSSARI superan a sus pasivos a corto plazo (₹4.7B).

Pasivo a largo plazo: Los activos a corto plazo de ROSSARI (₹8.4B) superan a sus pasivos a largo plazo (₹871.9M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (5.4%) de ROSSARI se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de ROSSARI ha crecido de 7.5% a 13.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de ROSSARI está bien cubierta por el flujo de caja operativo (48%).

Cobertura de intereses: Los pagos de intereses de la deuda de ROSSARI están bien cubiertos por el BAIT (9.3x cobertura).

Hoja de balance

Descubre empresas con salud financiera

7D

1Y

7D

1Y

7D

1Y